Cancer Care Ontario | Cancer Care Ontario

You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.

Skip to main content Skip to search

4 Results

Guidelines and Advice

T-Cell Engaging Antibodies: Management of Cytokine Release Syndrome (CRS) and Immune Effector-Associated Neurotoxicity Syndrome (ICANS)

Status: Current

Mar 2025

Guidelines and Advice

Systemic Treatment Emergency Preparedness Guidance Document

Status: Current

Aug 2025

Guidelines and Advice

Systemic Treatments for Unresectable and Metastatic Cutaneous Melanoma

Status: Current
ID: GL 8-12

Updated

Jan 2026

Guidelines and Advice

Treatment of Multiple Myeloma: ASCO–Ontario Health (Cancer Care Ontario) Living Guideline

Status: Current
ID: GL 6-A-2023-1
Version: 2

Updated

Jan 2026